Juniper Pharma (JNP) Tops Q3 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Juniper Pharmaceuticals Reports Third Quarter 2015 Financial Results
November 10, 2015 4:30 PM ESTBOSTON, Nov. 10, 2015 /PRNewswire/ -- Juniper Pharmaceuticals, Inc. (Nasdaq: JNP) ("Juniper" or the "Company"), a women's health therapeutics company, today announced financial results for the three months ended September 30, 2015. Highlights include:
Total revenues of $11.5 million, driven by a 22% year-over-year increase in CRINONE® (progesterone gel) product sales to Merck KGaA, Darmstadt, Germany, and 35% growth in service revenues; Merck KGaA was granted new marketing authorizations for CRINONE® in nine E.U. countries; Patient enrollment continues in the Phase 2b clinical study of... MoreJuniper Pharmaceuticals Announces Speakers for November 11, 2015 Investor Day
November 10, 2015 8:02 AM ESTBOSTON, Nov. 10, 2015 /PRNewswire/ --Â Juniper Pharmaceuticals, Inc. (Nasdaq: JNP) ("Juniper" or the "Company"), a women's health specialty pharmaceutical company, today announced the slate of speakers expected to present at its Investor Day on November 11 at the Union League Club in NYC.
Juniper's executive management team will be joined by members of its Scientific Advisory Board who will provide insights into its pipeline and key development programs. Scientific presentations will be given by:
Ginger Constantine, MDFormer Head of... More